Lima AL, Illing T, Schliemann S, Elsner P. Cutaneous manifestations of diabetes mellitus: a review. Am J Clin Dermatol. 2017;18:541–53.

Article  PubMed  Google Scholar 

Ansari MA, Chauhan W, Shoaib S, Alyahya SA, Ali M, Ashraf H, et al. Emerging therapeutic options in the management of diabetes: recent trends, challenges and future directions. Int J Obes. 2023;47:1179–99.

Article  Google Scholar 

Liu Z, Ma S. Recent advances in synthetic α‐glucosidase inhibitors. Chem Med Chem. 2017;12:819–29.

Article  PubMed  CAS  Google Scholar 

Balakumar P, Maung UK, Jagadeesh G. Prevalence and prevention of cardiovascular disease and diabetes mellitus. Pharmacol Res. 2016;113:600–9.

Article  PubMed  Google Scholar 

Pacaud D, Schwandt A, de Beaufort C, Casteels K, Beltrand J, Birkebaek NH, et al. A description of clinician reported diagnosis of type 2 diabetes and other non-type 1 diabetes included in a large international multicentered pediatric diabetes registry (SWEET). Pediatr Diabetes. 2016;17:24–31.

Article  PubMed  CAS  Google Scholar 

Tan SY, Mei Wong JL, Sim YJ, Wong SS, Mohamed Elhassan SA, Tan SH, et al. Type 1 and 2 diabetes mellitus: a review on current treatment approach and gene therapy as potential intervention. Diabetes Metab Syndr: Clin Res Rev. 2019;13:364–72.

Article  Google Scholar 

Jeyagaran A, Lu C, Zbinden A, Birkenfeld AL, Brucker SY, Layland SL. Type 1 diabetes and engineering enhanced islet transplantation. Adv Drug Deliv Rev. 2022;189:114481.

Article  PubMed  CAS  Google Scholar 

Chao P-C, Li Y, Chang C-H, Shieh JP, Cheng J-T, Cheng K-C. Investigation of insulin resistance in the popularly used four rat models of type-2 diabetes. Biomed Pharmacother. 2018;101:155–61.

Article  PubMed  CAS  Google Scholar 

Flack JR, Ross GP, Cheung NW. GCK monogenic diabetes and gestational diabetes: possible diagnosis on clinical grounds. Diabet Med. 2015;32:1596–601.

Article  PubMed  CAS  Google Scholar 

Farwa U, Raza MA. Heterocyclic compounds as a magic bullet for diabetes mellitus: a review. RSC Adv. 2022;12:22951–73.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Borges de Melo E, da Silveira, Gomes A, Carvalho I. α- and β-glucosidase inhibitors: chemical structure and biological activity. Tetrahedron. 2006;62:10277–302.

Article  CAS  Google Scholar 

Wang J, Lu S, Sheng R, Fan J, Wu W, Guo R. Structure-activity relationships of natural and synthetic indole-derived scaffolds as α-glucosidase inhibitors: a mini-review. Mini Rev Med Chem. 2020;20:1791–818.

Article  PubMed  CAS  Google Scholar 

Bashary R, Vyas M, Nayak SK, Suttee A, Verma S, Narang R, et al. An insight of alpha-amylase inhibitors as a valuable tool in the management of type 2 diabetes mellitus. Curr Diabetes Rev. 2019;16:117–36.

Google Scholar 

Chaudhry F, Choudhry S, Huma R, Ashraf M, al-Rashida M, Munir R, et al. Hetarylcoumarins: synthesis and biological evaluation as potent α -glucosidase inhibitors. Bioorg Chem. 2017;73:1–9.

Article  PubMed  CAS  Google Scholar 

Dhameja M, Gupta P. Synthetic heterocyclic candidates as promising α-glucosidase inhibitors: an overview. Eur J Med Chem. 2019;176:343–77.

Article  PubMed  CAS  Google Scholar 

Qaid MM, Abdelrahman MM. Role of insulin and other related hormones in energy metabolism–a review. Cogent Food Agric. 2016;2:1267691.

Google Scholar 

Dash RP, Babu RJ, Srinivas NR. Reappraisal and perspectives of clinical drug–drug interaction potential of α-glucosidase inhibitors such as acarbose, voglibose and miglitol in the treatment of type 2 diabetes mellitus. Xenobiotica. 2018;48:89–108.

Article  PubMed  CAS  Google Scholar 

Sugihara H, Nagao M, Harada T, Nakajima Y, Tanimura‐Inagaki K, Okajima F, et al. Comparison of three Α‐glucosidase inhibitors for glycemic control and bodyweight reduction in j apanese patients with obese type 2 diabetes. J Diabetes Investig. 2014;5:206–12.

Article  PubMed  CAS  Google Scholar 

Kaku K. Efficacy of voglibose in type 2 diabetes. Expert Opin Pharmacother. 2014;15:1181–90.

Article  PubMed  CAS  Google Scholar 

Usman B, Sharma N, Satija S, Mehta M, Vyas M, Khatik GL, et al. Recent developments in alpha-glucosidase inhibitors for management of type-2 diabetes: an update. Curr Pharm Des. 2019;25:2510–25.

Article  PubMed  CAS  Google Scholar 

Mahmood NA. Review of α-amylase inhibitors on weight loss and glycemic control in pathological state such as obesity and diabetes. Comp Clin Path. 2016;25:1253–64.

Article  CAS  Google Scholar 

Sun Y, Zhang C, Gao L, Liu M, Yang Y, Shao A, et al. Design, synthesis and evaluation of fluorescent properties of benzothiazole derivatives. Chem Phys Chem. 2023;24:e202300159.

Article  PubMed  CAS  Google Scholar 

Djuidje EN, Sciabica S, Buzzi R, Dissette V, Balzarini J, Liekens S, et al. Design, synthesis and evaluation of benzothiazole derivatives as multifunctional agents. Bioorg Chem. 2020;101:103960.

Article  PubMed  CAS  Google Scholar 

Ahmed K, Yellamelli Valli Venkata S, Mohammed NAK, Sultana F, Methuku KR. Recent advances on structural modifications of benzothiazoles and their conjugate systems as potential chemotherapeutics. Expert Opin Investig Drugs. 2012;21:619–35.

Article  PubMed  CAS  Google Scholar 

Pasternak L, Meltzer-Mats E, Babai-Shani G, Cohen G, Viskind O, Eckel J, et al. Benzothiazole derivatives augment glucose uptake in skeletal muscle cells and stimulate insulin secretion from pancreatic β-cells via Ampk activation. Chem Com. 2014;50:11222–5.

Article  CAS  Google Scholar 

Ahmadi A, Khalili M, Ghaderi P, Rastegar G, Nahri-Niknafs B. Synthesis and blood glucose and lipid-lowering effects of benzothiazole-substituted benzenesulfonylurea derivatives. Monatsh Chem. 2015;146:2059–65.

Article  CAS  Google Scholar 

Adams M, de Kock C, Smith PJ, Chibale K, Smith GS. Evaluation of ferrocenyl‐containing benzothiazoles as potential antiplasmodial agents. Eur J Inorg Chem. 2017;2017:242–6.

Article  CAS  Google Scholar 

Shah F, Wu Y, Gut J, Pedduri Y, Legac J, Rosenthal PJ, et al. Design, synthesis and biological evaluation of novel benzothiazole and triazole analogs as falcipain inhibitors. Med chem comm. 2011;2:1201.

Article  CAS  Google Scholar 

Diao P-C, Lin W-Y, Jian X-E, Li Y-H, You W-W, Zhao P-L. Discovery of novel pyrimidine-based benzothiazole derivatives as potent cyclin-dependent kinase 2 inhibitors with anticancer activity. Eur J Med Chem. 2019;179:196–207.

Article  PubMed  CAS  Google Scholar 

Hassan AY, Sarg MT, Hussein EM. Design, synthesis, and anticancer activity of novel benzothiazole analogues. J Heterocycl Chem. 2019;56:1437–57.

Article  CAS  Google Scholar 

Venugopala KN, Khedr MA, Pillay M, Nayak SK, Chandrashekharappa S, Aldhubiab BE, et al. Benzothiazole analogs as potential anti-TB agents: computational input and molecular dynamics. J Biomol Struct Dyn. 2019;37:1830–42.

Article  PubMed  CAS  Google Scholar 

Venugopala KN, Chandrashekharappa S, Pillay M, Bhandary S, Kandeel M, Mahomoodally FM, et al. Synthesis and structural elucidation of novel benzothiazole derivatives as anti-tubercular agents: in-silico screening for possible target identification. Med Chem. 2019;15:311–26.

Article  PubMed  CAS  Google Scholar 

Chugunova E, Boga C, Sazykin I, Cino S, Micheletti G, Mazzanti A, et al. Synthesis and antimicrobial activity of novel structural hybrids of benzofuroxan and benzothiazole derivatives. Eur J Med Chem. 2015;93:349–59.

Article  PubMed  CAS